Sesen Bio Inc reports results for the quarter ended in June - Earnings Summary

Carisma Therapeutics

08/08/2022 14:32

* Sesen Bio Inc  SESN.OQ  reported a quarterly adjusted loss
of 16
cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 13 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Sesen Bio Inc's reported EPS for the quarter was a loss
of 16
cents​.
    * The mean earnings estimate of analysts had fallen by
about 18.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sesen Bio Inc shares had fallen by 9.8% this quarter and
lost 10.3% so far this year.
    * The company reported a quarterly loss of $31.96 million.
    * Wall Street's median 12-month price target for Sesen Bio
Inc is
$0.56 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 8
at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.13          -0.16          Missed
 Mar. 31 2022      -0.10          0.00           Beat
 Dec. 31 2021      -0.07          0.04           Beat
 Sep. 30 2021      -0.07          0.36           Beat